This evidence prompted a wide array of cellular studies aiming at evaluating the capacity of different chemicals to induce Nrf2 activity in the context of different neurodegenerative disorders, including ALS [152,153,154,155,156], AD [157,158], and PD [159,160]. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.